Inclusion Criteria :  -  Patients of any age with a diagnosis of familial dysautonomia ( FD ) with molecular confirmation of the IKBKAP mutation .  -  Ability to provide informed consent ( or assent ) and comply with the study protocol  Exclusion Criteria :  -  Subjects that do not wish to be a part of the study . 